Literature DB >> 16474098

Role of granulocyte macrophage colony-stimulating factor during gram-negative lung infection with Pseudomonas aeruginosa.

Megan N Ballinger1, Robert Paine, Carlos H C Serezani, David M Aronoff, Esther S Choi, Theodore J Standiford, Galen B Toews, Bethany B Moore.   

Abstract

Granulocyte macrophage colony-stimulating factor (GM-CSF) stimulates survival, proliferation, differentiation, and function of myeloid cells. Recently, GM-CSF has been shown to be important for normal pulmonary homeostasis. We report that GM-CSF is induced in lung leukocytes during infection with Gram-negative bacteria. Therefore, we postulated that deficiencies in GM-CSF would increase susceptibility to Gram-negative infection in vivo. After an intratracheal inoculum with Pseudomonas aeruginosa, GM-CSF-/- mice show decreased survival compared with wild-type mice. GM-CSF-/- mice show increased lung, spleen, and blood bacterial CFU. GM-CSF-/- mice are defective in the production of cysteinyl leukotrienes, prostaglandin E2, macrophage inflammatory protein, and keratinocyte-derived chemokine in lung leukocytes postinfection. Despite these defects, inflammatory cell recruitment is not diminished at 6 or 24 h postinfection, and the functional activity of polymorphonuclear leukocytes from the lung and peritoneum against P. aeruginosa is enhanced in GM-CSF-/- mice. In contrast, alveolar macrophage (AM) phagocytosis, killing, and H2O2 production are defective in GM-CSF-/- mice. Although the absence of GM-CSF has profound effects on AMs, peritoneal macrophages seem to have normal bactericidal activities in GM-CSF-/- mice. Defects in AM function may be related to diminished levels of IFN-gamma and TNF-alpha postinfection. Thus, GM-CSF-/- mice are more susceptible to lung infection with P. aeruginosa as a result of impaired AM function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16474098      PMCID: PMC2644237          DOI: 10.1165/rcmb.2005-0246OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  37 in total

1.  Role of alveolar macrophages in initiation and regulation of inflammation in Pseudomonas aeruginosa pneumonia.

Authors:  K Kooguchi; S Hashimoto; A Kobayashi; Y Kitamura; I Kudoh; J Wiener-Kronish; T Sawa
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

2.  Effects of granulocyte-macrophage colony-stimulating factor on eicosanoid production by mononuclear phagocytes.

Authors:  T G Brock; R W McNish; M J Coffey; T C Ojo; S M Phare; M Peters-Golden
Journal:  J Immunol       Date:  1996-04-01       Impact factor: 5.422

3.  Lung phagocyte bactericidal function in strains of mice resistant and susceptible to Pseudomonas aeruginosa.

Authors:  C Morissette; C Francoeur; C Darmond-Zwaig; F Gervais
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

4.  GM-CSF-deficient mice are susceptible to pulmonary group B streptococcal infection.

Authors:  A M LeVine; J A Reed; K E Kurak; E Cianciolo; J A Whitsett
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

5.  Leukotriene-deficient mice manifest enhanced lethality from Klebsiella pneumonia in association with decreased alveolar macrophage phagocytic and bactericidal activities.

Authors:  M B Bailie; T J Standiford; L L Laichalk; M J Coffey; R Strieter; M Peters-Golden
Journal:  J Immunol       Date:  1996-12-15       Impact factor: 5.422

6.  Granulocyte colony-stimulating factor administration to HIV-infected subjects augments reduced leukotriene synthesis and anticryptococcal activity in neutrophils.

Authors:  M J Coffey; S M Phare; S George; M Peters-Golden; P H Kazanjian
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

7.  Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology.

Authors:  E Stanley; G J Lieschke; D Grail; D Metcalf; G Hodgson; J A Gall; D W Maher; J Cebon; V Sinickas; A R Dunn
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

8.  Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis.

Authors:  G Dranoff; A D Crawford; M Sadelain; B Ream; A Rashid; R T Bronson; G R Dickersin; C J Bachurski; E L Mark; J A Whitsett
Journal:  Science       Date:  1994-04-29       Impact factor: 47.728

9.  5-Lipoxygenase reaction products modulate alveolar macrophage phagocytosis of Klebsiella pneumoniae.

Authors:  P Mancuso; T J Standiford; T Marshall; M Peters-Golden
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

10.  Pulmonary epithelial cell expression of GM-CSF corrects the alveolar proteinosis in GM-CSF-deficient mice.

Authors:  J A Huffman; W M Hull; G Dranoff; R C Mulligan; J A Whitsett
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

View more
  55 in total

1.  Pulmonary fibrosis induced by γ-herpesvirus in aged mice is associated with increased fibroblast responsiveness to transforming growth factor-β.

Authors:  Payal N Naik; Jeffrey C Horowitz; Thomas A Moore; Carol A Wilke; Galen B Toews; Bethany B Moore
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-12-21       Impact factor: 6.053

2.  Impaired pulmonary immunity post-bone marrow transplant.

Authors:  Stephanie M Coomes; Leah L N Hubbard; Bethany B Moore
Journal:  Immunol Res       Date:  2011-05       Impact factor: 2.829

3.  Role of macrophage chemoattractant protein-1 in acute inflammation after lung contusion.

Authors:  Madathilparambil V Suresh; Bi Yu; David Machado-Aranda; Matthew D Bender; Laura Ochoa-Frongia; Jadwiga D Helinski; Bruce A Davidson; Paul R Knight; Cory M Hogaboam; Bethany B Moore; Krishnan Raghavendran
Journal:  Am J Respir Cell Mol Biol       Date:  2012-01-26       Impact factor: 6.914

4.  Local delivery of GM-CSF protects mice from lethal pneumococcal pneumonia.

Authors:  Kathrin Steinwede; Ole Tempelhof; Kristine Bolte; Regina Maus; Jennifer Bohling; Bianca Ueberberg; Florian Länger; John W Christman; James C Paton; Kjetil Ask; Shyam Maharaj; Martin Kolb; Jack Gauldie; Tobias Welte; Ulrich A Maus
Journal:  J Immunol       Date:  2011-10-14       Impact factor: 5.422

Review 5.  The molecular basis of pulmonary alveolar proteinosis.

Authors:  Brenna Carey; Bruce C Trapnell
Journal:  Clin Immunol       Date:  2010-03-25       Impact factor: 3.969

Review 6.  Eicosanoid regulation of pulmonary innate immunity post-hematopoietic stem cell transplantation.

Authors:  Megan N Ballinger; Tracy R McMillan; Bethany B Moore
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007 Jan-Feb       Impact factor: 4.291

7.  Identification of a role for TRIM29 in the control of innate immunity in the respiratory tract.

Authors:  Junji Xing; Leiyun Weng; Bin Yuan; Zhuo Wang; Li Jia; Rui Jin; Hongbo Lu; Xian Chang Li; Yong-Jun Liu; Zhiqiang Zhang
Journal:  Nat Immunol       Date:  2016-10-03       Impact factor: 25.606

8.  Response of Differentiated Human Airway Epithelia to Alcohol Exposure and Klebsiella Pneumoniae Challenge.

Authors:  Sammeta V Raju; Richard G Painter; Gregory J Bagby; Steve Nelson; Guoshun Wang
Journal:  Med Sci (Basel)       Date:  2013-07-26

9.  Paradoxical role of alveolar macrophage-derived granulocyte-macrophage colony-stimulating factor in pulmonary host defense post-bone marrow transplantation.

Authors:  Megan N Ballinger; Leah L N Hubbard; Tracy R McMillan; Galen B Toews; Marc Peters-Golden; Robert Paine; Bethany B Moore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-05-02       Impact factor: 5.464

10.  Macrophage dysfunction and susceptibility to pulmonary Pseudomonas aeruginosa infection in surfactant protein C-deficient mice.

Authors:  Stephan W Glasser; Albert P Senft; Jeffrey A Whitsett; Melissa D Maxfield; Gary F Ross; Theresa R Richardson; Daniel R Prows; Yan Xu; Thomas R Korfhagen
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.